Establishment Labs Holdings (ESTA) Accounts Payables (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Accounts Payables came in at $41.8 million in Q1 2026, down 7.47% year-on-year from $45.2 million in Q1 2025, and down 3.01% quarter-over-quarter from $43.1 million in Q4 2025.
Establishment Labs Holdings (ESTA) Accounts Payables (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Accounts Payables history runs 10 years deep, the most recent figure standing at $41.8 million for Q1 2026.
- On a quarterly basis, Accounts Payables fell 7.47% year-over-year to $41.8 million in Q1 2026; TTM through Mar 2026 was $41.8 million, a 7.47% decrease from a year earlier, with the FY2025 full-year figure at $43.1 million, down 3.69% from the prior year.
- Accounts Payables retreated to $41.8 million in Q1 2026 per ESTA's latest filing, from $43.1 million in the prior quarter.
- Across five years, Accounts Payables topped out at $55.8 million in Q2 2025 and bottomed at $14.9 million in Q3 2022.
- The 5-year median for Accounts Payables is $31.1 million (2024), against an average of $32.2 million.
- Across the five-year window, Accounts Payables surged 107.77% in 2023 and fell 7.47% in 2026, its largest moves.
- Year by year, Accounts Payables stood at $20.0 million in 2022, then jumped by 107.77% to $41.6 million in 2023, then advanced by 7.53% to $44.8 million in 2024, then decreased by 3.69% to $43.1 million in 2025, then dropped by 3.01% to $41.8 million in 2026.
- Per Business Quant, the three latest ESTA Accounts Payables figures stand at $41.8 million (Q1 2026), $43.1 million (Q4 2025), and $39.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 41.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.81 Mn |
| Dec 31, 2025 | 43.11 Mn |
| Sep 30, 2025 | 39.72 Mn |
| Jun 30, 2025 | 55.81 Mn |
| Mar 31, 2025 | 45.19 Mn |
| Dec 31, 2024 | 44.76 Mn |
| Sep 30, 2024 | 34.40 Mn |
| Jun 30, 2024 | 28.42 Mn |
| Mar 31, 2024 | 31.07 Mn |
| Dec 31, 2023 | 41.62 Mn |
| Sep 30, 2023 | 28.93 Mn |
| Jun 30, 2023 | 24.36 Mn |
| Mar 31, 2023 | 20.25 Mn |
| Dec 31, 2022 | 20.03 Mn |
| Sep 30, 2022 | 14.88 Mn |
| Jun 30, 2022 | 15.99 Mn |
| Mar 31, 2022 | 16.65 Mn |
| Dec 31, 2021 | 14.48 Mn |
| Sep 30, 2021 | 10.26 Mn |
| Jun 30, 2021 | 10.02 Mn |